drugset / Trial / NCT01113593

A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease

NCT01113593 ↗

Phase 2 Completed 45 enrolled Dey
RandomizedCrossoverQuadruple-blindTreatment

Summary

The purpose of this study is to characterize the pharmacodynamic profile of Formoterol Fumarate and Foradil Aerolizer

Timeline

Start
2010-05
Primary completion
2010-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Foradil Aerolizer Unknown — Inhaled
Subject Formoterol Other / unclassified — Inhaled